HDFC Mutual Fund

HDFC Pharma and Healthcare Fund - IDCW Option - Direct Plan

HDFC Mutual Fund

Expense Ratio: 0.94
Risk: Very High
Equity Scheme - Sectoral/ Thematic
Plan: Direct
Benchmark: BSE Healthcare TRI
Inception: 14-09-2023
Exit Load: Nil
Fund Size:₹2,000.50 Cr

Performance

1Y
Fund20.84%
Cat. Avg.N/A
2Y
Fund24.58%
Cat. Avg.N/A
3Y
FundN/A
Cat. Avg.N/A
5Y
FundN/A
Cat. Avg.N/A
10Y
FundN/A
Cat. Avg.N/A
SI
Fund32.23%
Cat. Avg.N/A

Fund Facts

No available Data

Taxation

Within 1 Year (STCG (Short Term)):20%
After 1 Year (LTCG (Long Term)):12.5%

*Tax rates as per Finance Act 2024. Surcharge & cess may apply.

Allocation

Visualizing Fund's Exposure

Portfolio Holdings

Detailed breakdown of instruments.

Instrument
Val (Cr) % Assets
1Sun Pharmaceutical Industries Ltd.403.1210.20%
2Divis Laboratories Ltd.324.298.20%
3Glenmark Pharmaceuticals Ltd.268.106.78%
4Lupin Ltd.262.996.65%
5Alkem Laboratories Ltd.236.865.99%
6Max Healthcare Institute Limited235.515.96%
7Aster DM Healthcare Limited225.265.70%
8Ipca Laboratories Ltd.204.085.16%
9Acutaas Chemicals Limited173.484.39%
10Anthem Biosciences Limited169.534.29%

Similar Funds

SIP Returns

7th
PeriodSIP DateInv(₹)Val(₹)Abs(%)XIRR
1Y07 Aug, 256000071181+18.6%+41.6%
2Y07 Aug, 241.20 L.1.51 L.+25.9%+25.5%
SI09 Oct, 231.70 L.2.43 L.+42.9%+27.4%

Lumpsum Returns

PeriodInv DateInv(₹)Val(₹)Abs(%)CAGR
1Y15 Jul, 251 L.1.21 L.+20.8%+20.9%
2Y15 Jul, 241 L.1.55 L.+55.2%+24.6%
SI04 Oct, 231 L.2.17 L.+117.5%+32.3%

SIP Planner

Visualize how small monthly investments grow over time.

Years
%
%

Beat inflation and compound wealth faster with an annual step-up.

%
%
Future Value

₹23.80L

With SIP Amount ₹5,000
Total Invested
₹9.00L
Total Gained
₹14.80L
SIP Invested₹9.00L
SIP Gain₹14.80L
Lumpsum Inv.₹0
Lumpsum Gain₹0

Reality Check: Your future value will be today's ₹8.62L at inflation rate 7%

Tip: You can set a Goal first in the Goal Planner to calculate SIP targets adjusted for inflation.

Search Funds